Vitals, which provides pricing transparency and reviews of physicians, named Heyward Donigan as its new CEO, replacing Mitch Rothschild, while appointing former Priceline Group CEO Jeffrey Boyd to adviser and board director.
Donigan was previously CEO of ValueOptions, a health improvement company that specializes in mental and emotional well-being and recovery. There, she helped drive revenues to over $1 billion. The company was acquired by Boston-based Beacon Health Strategies late in 2014. Prior to ValueOptions, Donigan was executive vice president and chief marketing officer at Premera Blue Cross.
Boyd is chairman of The Priceline Group and served as its CEO from 2002 to 2013. Before joining Priceline, he served as executive vice president, general counsel and secretary of Oxford Health Plans.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Over the past three years, Vitals said it has seen its revenue nearly quadruple as it expanded into the busy digital health and transparency space. In October last year, Vitals acquired Compass Healthcare Advisers as a way to add to its physician comparison and cost calculator tools.
Rothschild, who co-founded New Jersey-based Vitals, will continue as chairman.
